Aiming to recognize those cancer types in which PREX1 expression correlates with shorter patient survival and identify its potential signaling partners, we analyzed transcriptomic datasets of 21 TCGA studies (https://www.cancer.gov/tcga). This evidence concerns the gene PREX1 and cancer.